40
Participants
Start Date
April 30, 2013
Primary Completion Date
August 31, 2015
Study Completion Date
October 31, 2015
Belimumab
10mg/kg IV infusion
Placebo
placebo IV infusion
GSK Investigational Site, Berlin
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Milan
GSK Investigational Site, Charlottesville
GSK Investigational Site, Charleston
GSK Investigational Site, Miami
GSK Investigational Site, Tampa
GSK Investigational Site, Columbus
GSK Investigational Site, Cologne
GSK Investigational Site, Kansas City
GSK Investigational Site, Tübingen
GSK Investigational Site, Houston
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Phoenix
GSK Investigational Site, Los Angeles
GSK Investigational Site, Orange
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Hershey
GSK Investigational Site, Burlington
GSK Investigational Site, Edmonton
GSK Investigational Site, Vancouver
GSK Investigational Site, London
GSK Investigational Site, Toronto
GSK Investigational Site, Leipzig
GSK Investigational Site, Rome
Lead Sponsor
GlaxoSmithKline
INDUSTRY